SCHEMBL5116413

SCHEMBL5116413

Cc1cc(COc2c(C)cc(NC(=O)CC(=O)O)cc2C)cc(NC(=O)C(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 4/20 0.46
THRA P10827 3/20 0.46
ALDH1A1 P00352 2/20 0.42
SENP5 Q96HI0 1/20 0.40
SENP2 Q9HC62 1/20 0.40
SENP1 Q9P0U3 1/20 0.40
KMT2A Q03164 6/20 0.38
MEN1 O00255 3/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
FFAR4 Q5NUL3 2/20 0.36
FFAR1 O14842 1/20 0.36
HDAC8 Q9BY41 1/20 0.35
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 1/20 0.35
PTGER1 P34995 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5119273 0.89 KMT2A (0.40) THRBTHRAALDH1A1SENP5SENP2
SCHEMBL5113278 0.89 THRA (0.44) THRBTHRAALDH1A1SENP5SENP2
SCHEMBL5104495 0.89 THRA (0.46) THRBTHRAALDH1A1SENP5SENP2
SCHEMBL4929827 0.88 THRB (0.46) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL5111642 0.87 KMT2A (0.46) THRBTHRAALDH1A1SENP5SENP2
SCHEMBL4931960 0.87 ALDH1A1 (0.45) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL5111499 0.87 ALDH1A1 (0.58) THRBTHRAALDH1A1SENP5SENP2
SCHEMBL5109913 0.86 ALDH1A1 (0.46) THRBTHRAALDH1A1SENP5SENP2
SCHEMBL4932089 0.85 THRB (0.43) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL4932767 0.85 ALDH1A1 (0.46) THRBTHRAALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRB 4/4885THRA 3/4885ALDH1A1 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.